Chaga Mushroom

What this page covers:what published research (all animal/lab-stage, no human trials yet) shows about Chaga, the real kidney-injury case reports on record, and what "wild-harvested" vs. "cultivated" actually means for what's in the bottle. It does not evaluate other mushroom species or make treatment claims. See Memorial Sloan Kettering's clinical summary for a fuller clinical picture.

In one line

No human clinical trials exist for Chaga yet, only animal and lab research; lab-cultivated Chaga mycelium cannot contain betulinic acid at all (only wild sclerotium in contact with a birch tree can); and heavy Chaga use has real, documented case reports of serious kidney injury tied to its naturally high oxalate content.

What the research actually shows

Chaga (Inonotus obliquus) has antioxidant, antidiabetic, antiviral, immunomodulating, and anti-inflammatory effects reported across laboratory and animal studies, but no completed human clinical trial has evaluated its safety or effectiveness as of this writing. One representative animal study fed diabetic rats fermented Chaga polysaccharides at 10, 20, and 30 mg/kg for 6 weeks, per Diao et al., and found dose-dependent blood glucose reduction (over 50% at the highest dose) and recovery of damaged pancreatic beta-cell structure. That's a real, measured effect, in rats, not people, at a dose that hasn't been translated to a human equivalent in any published trial. Any product or article claiming a specific human benefit from Chaga is going beyond what the current evidence actually supports.

"Wild-harvested" vs. "cultivated": not a subtle difference

Unlike Lion's Mane, Reishi, or Cordyceps, where fruiting-body vs. mycelium is mostly a concentration and verification question, Chaga's wild-vs-cultivated split is a hard compositional ceiling. Chaga is a sclerotium, a dense mass the fungus forms only after years of parasitizing a living birch tree, drawing betulin from the bark and converting it into betulinic acid and related triterpenoids. Per Real Mushrooms' own published explanation, lab-cultivated Chaga mycelium grown on grain substrate, without contact with a birch tree, cannot contain betulinic acid at all, no matter how the product is marketed.

Chaga source material, by brand-published data
Source type	Compounds	What brand data shows	Label example
Wild-harvested sclerotium (birch tree)	Betulin, betulinic acid, inotodiol, melanin, beta-glucans	Chaga draws betulin from the birch tree it parasitizes and converts it into betulinic acid and related triterpenoids, per Nootropics Depot's own product page. This conversion only happens through years of contact with a living birch tree.	A label stating "wild-harvested" or "wild sclerotia" and naming a cold-climate region (Siberia, Northern Europe) indicates this source.
Cultivated mycelium (grain substrate)	Some polysaccharides; no birch-derived compounds	Per Real Mushrooms' own published comparison, lab-cultivated Chaga mycelium grown on grain, without contact with a living birch tree, cannot contain betulinic acid or the other birch-derived compounds at all, regardless of how the product is marketed.	A label saying "chaga mycelium" or listing grain/rice as a substrate, without the word "wild," is very likely this type.

Is it safe? This is the most important section on this page

Chaga naturally contains high levels of oxalates. At high, sustained doses this has caused real kidney injury. Per Kim et al., 2020, Journal of Korean Medical Science, a 49-year-old man developed end-stage renal disease after long-term Chaga powder use for a skin condition; his biopsy showed oxalate crystal deposits, and the Chaga he'd consumed tested at 14.2 g of oxalate per 100 g. Per a separate 2022 case report, a 69-year-old man developed acute kidney injury with nephrotic syndrome after 10-15 g/day of Chaga powder plus 500 mg/day vitamin C for 3 months; he recovered within a month after hemodialysis and high-dose steroids, but the injury was real and required hospital-level treatment. These aren't theoretical risks; they're published, named cases. See the Chaga Dosage & Consumption page for what doses these cases involved and who should avoid Chaga entirely.

This page does not evaluate other medication interactions or every possible risk; check with a doctor before starting any supplement, especially if you have any history of kidney disease, are pregnant, on medication, or allergic to mushrooms.

For consumption forms and dosing detail, see Chaga Dosage & Consumption. Chaga is also compared against Cordyceps, Reishi, and Lion's Mane research on the Cordyceps hub, Reishi hub, and Lion's Mane hub. Chaga as a coffee-blend ingredient is covered separately on the Mushroom Coffee hub.

Named brands, checked one at a time

Beyond the source-material comparison above, named brands get a dedicated look at what their own label actually discloses: Nootropics Depot (wild-harvested whole fruiting body, dual-extracted, minimum 8% beta-glucans, third-party ISO-lab tested), Real Mushrooms(100% wild-harvested sclerotia, hot-water extracted, >30% beta-glucans guaranteed, NMR species-verified), and Host Defense (mycelium grown on fermented rice, wild-vs-cultivated status not disclosed, no beta-glucan percentage published).

Frequently Asked Questions

Is Chaga backed by human clinical trials?

No. As of this writing, no completed human clinical trials have evaluated Chaga's safety or effectiveness. The antioxidant, antidiabetic, and immunomodulating effects reported for Chaga come from laboratory (in vitro) and animal studies, not human trials. Treat any specific numeric benefit claim for Chaga with that limitation in mind.

Does the wild-harvested vs. cultivated distinction actually matter for Chaga?

Yes, more than for most other functional mushrooms on this site. Per Real Mushrooms' own published comparison, lab-cultivated Chaga mycelium grown on grain substrate cannot contain betulinic acid or other birch-derived compounds at all, because those compounds only form through the fungus's years-long relationship with a living birch tree. This isn't a subtle extraction-method difference; it's a hard compositional ceiling.

Is Chaga safe?

There are real, documented risks at high doses. Three published case reports describe kidney injury linked to heavy Chaga consumption, including one patient who required hemodialysis after 10-15 g/day for 3 months, and another who developed end-stage renal disease after years of long-term use. The mechanism is Chaga's naturally high oxalate content. See the Dosage & Consumption page for the specific case details and who should avoid Chaga entirely.

Does Chaga interact with medications?

Per Memorial Sloan Kettering's clinical summary, Chaga extract inhibited platelet aggregation in animal research and may have additive effects with blood-thinning medication, though clinical relevance in humans isn't established. It also showed additive blood-sugar-lowering effects in vitro. Anyone on anticoagulants, antiplatelet drugs, or diabetes medication should talk to a doctor before using Chaga.

How is Chaga usually taken?

As a tea, tincture, powder, or capsule, most often from an extract rather than raw chunks. There's no established human clinical dose since no human trials exist; see our dosage and consumption-methods guide for what's actually documented, including the doses linked to kidney injury in the case reports above.

Sources

Diao et al., Chaga mushroom polysaccharides in streptozotocin-induced diabetic rats: Animal study, not human: fermented Chaga polysaccharides 10/20/30 mg/kg for 6 weeks in diabetic rats; dose-dependent blood glucose reduction and beta-cell structure recovery
Kim et al., 2020, Journal of Korean Medical Science: Case report: 49-year-old man, end-stage renal disease after long-term Chaga powder use for atopic dermatitis; biopsy showed chronic tubulointerstitial nephritis with oxalate crystal deposits; measured Chaga oxalate content 14.2 g/100g
Case report, 2022, oxalate nephropathy: 69-year-old man, 10-15 g/day Chaga powder plus 500mg/day vitamin C for 3 months; acute kidney injury with nephrotic syndrome; recovered within 1 month after hemodialysis and high-dose steroids
Memorial Sloan Kettering Cancer Center, Chaga Mushroom clinical summary: Clinical safety review: platelet aggregation inhibition in animal models, additive blood-sugar effects in vitro, 3 case reports of kidney damage
Nootropics Depot, Chaga Whole Fruiting Body Extract product page: Brand's own disclosure of wild-harvested source, dual-extraction method, and betulinic acid formation from birch contact
Real Mushrooms, "What is Chaga" educational article: Brand's own explanation of why lab-cultivated Chaga mycelium cannot contain betulinic acid or other birch-derived compounds